Made Sick from Prostate Cancer Awareness and Screening

Prominent physician, Dr. Bert Vorstman, warns about overreacting during prostate cancer awareness month.

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friend
75% of all prostate cancers detected are the insignificant Gleason 6 (3+3) “cancers” which are not a health risk and commonly overtreated or treated unnecessarily.

Miami, FL (PRWEB) September 12, 2013

Prominent Florida prostate cancer specialist, Bert Vorstman MD, MS, FAAP, FRACS, FACS, has posted his latest blog, “Made Sick from Prostate Cancer Awareness and Screening” on his URO HEALTH blog site.Dr Bert Vorstman is a Coral Springs based urological surgeon and patient advocate with some 30 years of surgical experience.

Dr. Vorstman cautions men and their wives/partners to be very, very wary about undergoing prostate cancer screening, particularly during the Prostate Cancer Awareness Month of September as the risks and harms associated with the screening and treatment of screen detected prostate cancer are very high and without significant life-saving benefits.

Said Dr. Vorstman, “75% of all prostate cancers detected are the insignificant Gleason 6 (3+3) “cancers” which are not a health risk and commonly overtreated or treated unnecessarily. In fact, there is zero justification for calling the Gleason 6 (3+3) lesion a cancer. Furthermore, the use of the toxic, high-risk and irreversible robotic prostatectomy for any prostate cancer has never been validated scientifically.” Dr. Vorstman also noted, “Even the embarrassing USPSTF report underscored once more the lack of benefits from prostate cancer screening and the great harm incurred along with insignificant numbers of lives saved from the treatment of screen-detected prostate cancer.”

Dr. Vorstman’s passion in medicine is the empowerment of men and their wives/partners about the pitfalls concerning localized prostate cancer, management options and health choices. He is a dedicated patient advocate and outspoken critic of overdiagnosis and overtreatment of the favorable-risk Gleason 6 (3+3) prostate “cancer”. His powerful messages and insights regarding localized prostate cancer management reach many people through his website and blog, http://www.urologyweb.com. To review Dr. Vorstman’s extensive writings on localized prostate cancer management go to http://www.urologyweb.com/uro-health-blog/ or contact Dr. Bert Vorstman at 877 783 4438 or, bvorstmanmd(at)gmail(dot)com.


Contact

  • Dr. Bert Vorstman
    UrologyWeb
    +1 704-414-0221
    Email